Network structure of brain atrophy in de novo parkinson’s disease

eLife

Volumn 4, Issue September 2015, 2015, Pages

  Zeighami, Yashar ^a   Ulla, Miguel ^a,b   Iturria Medina, Yasser ^a   Dadar, Mahsa ^a   Zhang, Yu ^a   Larcher, Kevin Michel Herve ^a   Fonov, Vladimir ^a   Evans, Alan C ^a   Collins, D Louis ^a   Dagher, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGING; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; CONNECTOME; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; FEMALE; FOREBRAIN; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENDER; GRAY MATTER; HUMAN; INNERVATION; MALE; MEDIAL TEMPORAL LOBE; MESENCEPHALON; MORPHOMETRICS; NERVE CELL NETWORK; NORMAL HUMAN; PARKINSON DISEASE; SUBSTANTIA NIGRA; ADOLESCENT; ATROPHY; BIOMETRY; BRAIN; DIAGNOSTIC IMAGING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; ATROPHY; BIOMETRY; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; RADIOGRAPHY; YOUNG ADULT;

EID: 84943774064     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08440     Document Type: Article

References (74)

1. Amunts K, Lepage C, Borgeat L, Mohlberg H, Dickscheid T, Rousseau MÉ, Bludau S, Bazin PL, Lewis LB, Oros-Peusquens AM, Shah NJ, Lippert T, Zilles K, Evans AC. 2013. BigBrain: an ultrahigh-resolution 3D human brain model. Science 340:1472-1475. doi: 10.1126/science.1235381.
2. Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM. 2010. Hippocampal, caudate, and ventricular changes in Parkinson’s disease with and without dementia. Movement Disorders 25:687-695. doi: 10.1002/mds.22799.
3. Ashburner J, Friston KJ. 2000. Voxel-based morphometry—the methods. Neuroimage 11:805-821. doi: 10.1006/nimg.2000.0582.
4. Aubert-Broche B, Fonov VS, García-Lorenzo D, Mouiha A, Guizard N, Coupé P, Eskildsen SF, Collins DL. 2013. A new method for structural volume analysis of longitudinal brain MRI data and its application in studying the growth trajectories of anatomical brain structures in childhood. Neuroimage 82:393-402. doi: 10.1016/j.neuroimage.2013.05.065.
5. Bartra O, McGuire JT, Kable JW. 2013. The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. Neuroimage 76:412-427. doi: 10.1016/j.neuroimage.2013.02.063.
6. Bassett DS, Bullmore E, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. 2008. Hierarchical organization of human cortical networks in health and schizophrenia. The Journal of Neuroscience 28:9239-9248. doi: 10.1523/JNEUROSCI.1929-08.2008.
7. Beckmann CF, Smith SM. 2004. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Transactions on Medical Imaging 23:137-152. doi: 10.1109/TMI.2003.822821.
8. Beckmann CF, Smith SM. 2005. Tensorial extensions of independent component analysis for multisubject FMRI analysis. Neuroimage 25:294-311. doi: 10.1016/j.neuroimage.2004.10.043.
9. Bellec P, Rosa-Neto P, Lyttelton OC, Benali H, Evans AC. 2010. Multi-level bootstrap analysis of stable clusters in resting-state fMRI. Neuroimage 51:1126-1139. doi: 10.1016/j.neuroimage.2010.02.082.
10. Bellec P, Lavoie-Courchesne S, Dickinson P, Lerch JP, Zijdenbos AP, Evans AC. 2012. The pipeline system for Octave and Matlab (PSOM): a lightweight scripting framework and execution engine for scientific workflows. Front Neuroinformatics 6:7. doi: 10.3389/fninf.2012.00007.
11. Berridge KC. 2006. The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology 191:391-431. doi: 10.1007/s00213-006-0578-x.
12. Booij J, Knol RJJ. 2007. SPECT imaging of the dopaminergic system in (premotor) Parkinson’s disease. Parkinsonism & Related Disorders 13(Suppl 3):S425-S428. doi: 10.1016/S1353-8020(08)70042-7.
13. Borghammer P, Østergaard K, Cumming P, Gjedde A, Rodell A, Hall N, Chakravarty MM. 2010. A deformationbased morphometry study of patients with early-stage Parkinson’s disease. European Journal of Neurology 17:314-320. doi: 10.1111/j.1468-1331.2009.02807.x.
14. Braak H, Tredici KD, Rüb U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging 24:197-211. doi: 10.1016/S0197-4580(02)00065-9.
15. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Tredici KD. 2004. Stages in the development of Parkinson’s diseaserelated pathology. Cell and Tissue Research 318:121-134. doi: 10.1007/s00441-004-0956-9.
16. Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Del Tredici K. 2006. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Movement Disorders 21:2042-2051. doi: 10.1002/mds.21065.
17. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA. 2009. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. The Journal of Neuroscience 29:1860-1873. doi: 10.1523/JNEUROSCI.5062-08.2009.
18. Calhoun VD, Adali T, Pearlson GD, Pekar JJ. 2001. A method for making group inferences from functional MRI data using independent component analysis. Human Brain Mapping 14:140-151. doi: 10.1002/hbm.1048.
19. Camicioli R. 2013. MR imaging of Parkinson’s disease with A cognitive impairment and dementia. Magnetic Resonance Imaging 44.
20. Carbonell F, Nagano-Saito A, Leyton M, Cisek P, Benkelfat C, He Y, Dagher A. 2014. Dopamine precursor depletion impairs structure and efficiency of resting state brain functional networks. Neuropharmacology 84:90-100. doi: 10.1016/j.neuropharm.2013.12.021.
21. Chung MK, Worsley KJ, Paus T, Cherif C, Collins DL, Giedd JN, Rapoport JL, Evans AC. 2001. A unified statistical approach to deformation-based morphometry. Neuroimage 14:595-606. doi: 10.1006/nimg.2001.0862.
22. Collins DL, Evans AC. 1997. Animal: validation and applications of nonlinear registration-based segmentation. International Journal of Pattern Recognition and Artificial Intelligence 11:1271-1294. doi: 10.1142/S0218001497000597.
23. Collins DL, Neelin P, Peters TM, Evans AC. 1994. Automatic 3D intersubject registration of MR volumetric data. Journal of Computer Assisted Tomography 18:192-205. doi: 10.1097/00004728-199403000-00005.
24. Coupe P, Yger P, Prima S, Hellier P, Kervrann C, Barillot C. 2008. An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images. IEEE Transactions on Medical Imaging 27:425-441. doi: 10.1109/TMI.2007.906087.
25. Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, Bullmore ET. 2014. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 137:2382-2395. doi: 10.1093/brain/awu132.
26. Damoiseaux JS, Rombouts S, Barkhof F, Scheltens P, Stam CJ, Smith SM, Beckmann CF. 2006. Consistent restingstate networks across healthy subjects. Proceedings of the National Academy of Sciences of USA 103: 13848-13853. doi: 10.1073/pnas.0601417103.
27. Daubechies I, Roussos E, Takerkart S, Benharrosh M, Golden C, D’Ardenne K, Richter W, Cohen JD, Haxby J. 2009. Independent component analysis for brain fMRI does not select for independence. Proceedings of the National Academy of Sciences of USA 106:10415-10422. doi: 10.1073/pnas.0903525106.
28. Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N. 2009. A probabilistic MR atlas of the human cerebellum. Neuroimage 46:39-46. doi: 10.1016/j.neuroimage.2009.01.045.
29. Douaud G, Groves AR, Tamnes CK, Westlye LT, Duff EP, Engvig A, Walhovd KB, James A, Gass A, Monsch AU, Matthews PM, Fjell AM, Smith SM, Johansen-Berg H. 2014. A common brain network links development, aging, and vulnerability to disease. Proceedings of the National Academy of Sciences of USA 111:17648-17653. doi: 10.1073/pnas.1410378111.
30. Duvernoy HM, Bonneville JF, Cabanis EA, Cattin F, Guyot J, Iba-Zizen MT. 1995. The human brain stem and cerebellum: surface, structure, vascularization, and three-dimensional sectional anatomy, with MRI. first edition, Springer. p. 430.
31. Eidelberg D. 2009. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends in Neurosciences 32:548-557. doi: 10.1016/j.tins.2009.06.003.
32. Fearnley JM, Lees AJ. 1991. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283-2301. doi: 10.1093/brain/114.5.2283.
33. Ford AA, Colon-Perez L, Triplett WT, Gullett JM, Mareci TH, FitzGerald DB. 2013. Imaging white matter in human brainstem. Frontiers in Human Neuroscience 7:400. doi: 10.3389/fnhum.2013.00400.
34. Fox MD, Raichle ME. 2007. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nature Reviews Neuroscience 8:700-711. doi: 10.1038/nrn2201.
35. Frost B, Diamond MI. 2010. Prion-like mechanisms in neurodegenerative diseases. Nature Reviews Neuroscience 11:155-159. doi: 10.1038/nrn2786.
36. Goedert M, Spillantini MG, Del Tredici K, Braak H. 2013. 100 years of Lewy pathology. Nature Reviews Neurology 9:13-24. doi: 10.1038/nrneurol.2012.242.
37. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force. 2008. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders 23:2129-2170. doi: 10.1002/mds.22340.
38. Greicius MD, Srivastava G, Reiss AL, Menon V. 2004. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proceedings of the National Academy of Sciences of USA 101:4637-4642. doi: 10.1073/pnas.0308627101.
39. Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, Mitchell TN, Brooks DJ, Duncan JS. 2003. Threedimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping 19:224-247. doi: 10.1002/hbm.10123.
40. He Y, Wang J, Wang L, Chen ZJ, Yan C, Yang H, Tang H, Zhu C, Gong Q, Zang Y, Evans AC. 2009. Uncovering intrinsic modular organization of spontaneous brain activity in humans. PLOS ONE 4:e5226. doi: 10.1371/journal.pone.0005226.
41. Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, Wang ZY, Roybon L, Melki R, Li JY. 2014. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathologica 128:805-820. doi: 10.1007/s00401-014-1343-6.
42. Hyvärinen A, Karhunen J, Oja E. 2004. Independent component analysis: John Wiley & Sons.
43. Ibarretxe-Bilbao N, Junque C, Marti MJ, Tolosa E. 2011. Brain structural MRI correlates of cognitive dysfunctions in Parkinson’s disease. Journal of the Neurological Sciences 310:70-74. doi: 10.1016/j.jns.2011.07.054.
44. Iturria-Medina Y, Canales-Rodríguez EJ, Melie-García L, Valdés-Hernández PA, Martínez-Montes E, Alemán-Gómez Y, Sánchez-Bornot JM. 2007. Characterizing brain anatomical connections using diffusion weighted MRI and graph theory. Neuroimage 36:645-660. doi: 10.1016/j.neuroimage.2007.02.012.
45. Iturria-Medina Y, Sotero RC, Toussaint PJ, Evans AC, Alzheimer’s Disease Neuroimaging Initiative. 2014. Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders. PLOS Computational Biology 10:e1003956. doi: 10.1371/journal.pcbi.1003956.
46. Jagust W. 2013. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 77:219-234. doi: 10.1016/j.neuron.2013.01.002.
47. Jucker M, Walker LC. 2013. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45-51. doi: 10.1038/nature12481.
48. Keuken MC, Bazin PL, Crown L, Hootsmans J, Laufer A, Müller-Axt C, Sier R, van der Putten EJ, Schäfer A, Turner R, Forstmann BU. 2014. Quantifying inter-individual anatomical variability in the subcortex using 7 T structural MRI. Neuroimage 94:40-46. doi: 10.1016/j.neuroimage.2014.03.032.
49. Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM. 2012. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949-953. doi: 10.1126/science.1227157.
50. Mai J, Assheuer J, Paxinos G. 2003. Atlas of the human brain. second edition, San Diego: Elsevier.
51. Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W, Mollenhauer B, Sherer T, Frasier M, Meunier C, Rudolph A, Casaceli C, Seibyl J, Mendick S, Schuff N, Zhang Y, Toga A, Crawford K, Ansbach A, De Blasio P, Piovella M, Trojanowski J, Shaw L, Singleton A, Hawkins K, Eberling J, Brooks D, Russell D, Leary L, Factor S, Sommerfeld B, Hogarth P, Pighetti E, Williams K, Standaert D, Guthrie S, Hauser R, Delgado H, Jankovic J, Hunter C, Stern M, Tran B, Leverenz J, Baca M, Frank S, Thomas CA, Richard I, Deeley C, Rees L, Sprenger F, Lang E, Shill H, Obradov S, Fernandez H, Winters A, Berg D, Gauss K, Galasko D, Fontaine D, Mari Z, Gerstenhaber M, Brooks D, Malloy S, Barone P, Longo K, Comery T, Ravina B, Grachev I, Gallagher K, Collins M, Widnell KL, Ostrowizki S, Fontoura P, La-Roche F, Ho T, Luthman J, van der Brug M, Reith AD, Taylor P. 2011. The parkinson progression marker initiative (PPMI). Progress in Neurobiology 95:629-635. doi: 10.1016/j.pneurobio.2011.09.005.
52. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M. 2013. Prionlike spreading of pathological α-synuclein in. Brain 136:1128-1138. doi: 10.1093/brain/awt037.
53. Olanow CW, Brundin P. 2013. Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Movement Disorders 28:31-40. doi: 10.1002/mds.25373.
54. Pereira JB, Svenningsson P, Weintraub D, Brønnick K, Lebedev A, Westman E, Aarsland D. 2014. Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 82:2017-2025. doi: 10.1212/WNL.0000000000000483.
55. Perlbarg V, Bellec P, Anton JL, Pélégrini-Issac M, Doyon J, Benali H. 2007. CORSICA: correction of structured noise in fMRI by automatic identification of ICA components. Magnetic Resonance Imaging 25:35-46. doi: 10.1016/j.mri.2006.09.042.
56. Pyatigorskaya N, Gallea C, Garcia-Lorenzo D, Vidailhet M, Lehericy S. 2014. A review of the use of magnetic resonance imaging in Parkinson’s disease. Therapeutic Advances in Neurological Disorders 7:206-220. doi: 10.1177/1756285613511507.
57. Raj A, Kuceyeski A, Weiner M. 2012. A network diffusion model of disease progression in dementia. Neuron 73:1204-1215. doi: 10.1016/j.neuron.2011.12.040.
58. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR. 2004. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Annals of Neurology 56:532-539. doi: 10.1002/ana.20226.
59. Salamone J, Correa M, Mingote S, Weber S. 2005. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Current Opinion in Pharmacology 5:34-41. doi: 10.1016/j.coph.2004.09.004.
60. Scanlon C, Mueller SG, Tosun D, Cheong I, Garcia P, Barakos J, Weiner MW, Laxer KD. 2011. Impact of methodologic choice for automatic detection of different aspects of brain atrophy by using temporal lobe epilepsy as a model. AJNR. American Journal of Neuroradiology 32. doi: 10.3174/ajnr.A2578.
61. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. 2009. Neurodegenerative diseases target large-scale human brain networks. Neuron 62:42-52. doi: 10.1016/j.neuron.2009.03.024.
62. Silbert LC, Kaye J. 2010. Neuroimaging and Cognition in Parkinson’s disease dementia. Brain Pathology 20:646-653. doi: 10.1111/j.1750-3639.2009.00368.x.
63. Sled JG, Zijdenbos AP, Evans AC. 1998. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Transactions on Medical Imaging 17:87-97. doi: 10.1109/42.668698.
64. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208-S219. doi: 10.1016/j.neuroimage.2004.07.051.
65. Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, Beckmann CF. 2009. Correspondence of the brain’s functional architecture during activation and rest. Proceedings of the National Academy of Sciences of USA 106:13040-13045. doi: 10.1073/pnas.0905267106.
66. Smith SM, Beckmann CF, Andersson J, Auerbach EJ, Bijsterbosch J, Douaud G, Duff E, Feinberg DA, Griffanti L, Harms MP, Kelly M, Laumann T, Miller KL, Moeller S, Petersen S, Power J, Salimi-Khorshidi G, Snyder AZ, Vu AT, Woolrich MW, Xu J, Yacoub E, Uğurbil K, Van Essen DC, Glasser MF, WU-Minn HCP Consortium. 2013. Restingstate fMRI in the Human Connectome Project. Neuroimage 80:144-168. doi: 10.1016/j.neuroimage.2013.05.039.
67. Stoodley CJ, Schmahmann JD. 2009. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 44:489-501. doi: 10.1016/j.neuroimage.2008.08.039.
68. Talairach J, Tournoux P. 1988. Co-planar stereotaxic atlas of the human brain. Stuttgart: Georg Thieme Verlag.
69. Varentsova A, Zhang S, Arfanakis K. 2014. Development of a high angular resolution diffusion imaging human brain template. Neuroimage 91:177-186. doi: 10.1016/j.neuroimage.2014.01.009.
70. Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN. 2013. Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends in Neurosciences 36:561-569. doi: 10.1016/j.tins.2013.06.007.
71. Worsley KJ, Liao CH, Aston J, Petre V, Duncan GH, Morales F, Evans AC. 2002. A general statistical analysis for fMRI data. Neuroimage 15:1-15. doi: 10.1006/nimg.2001.0933.
72. Worsley KJ. 2005. Spatial smoothing of autocorrelations to control the degrees of freedom in fMRI analysis. Neuroimage 26:635-641. doi: 10.1016/j.neuroimage.2005.02.007.
73. Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. 2012. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 73:1216-1227. doi: 10.1016/j.neuron.2012.03.004.
74. Zuo XN, Kelly C, Adelstein JS, Klein DF, Castellanos FX, Milham MP. 2010. Reliable intrinsic connectivity networks: test-retest evaluation using ICA and dual regression approach. Neuroimage 49:2163-2177. doi: 10.1016/j.neuroimage.2009.10.080.